» Articles » PMID: 28263189

CD11b Activation Suppresses TLR-dependent Inflammation and Autoimmunity in Systemic Lupus Erythematosus

Abstract

Genetic variations in the ITGAM gene (encoding CD11b) strongly associate with risk for systemic lupus erythematosus (SLE). Here we have shown that 3 nonsynonymous ITGAM variants that produce defective CD11b associate with elevated levels of type I interferon (IFN-I) in lupus, suggesting a direct link between reduced CD11b activity and the chronically increased inflammatory status in patients. Treatment with the small-molecule CD11b agonist LA1 led to partial integrin activation, reduced IFN-I responses in WT but not CD11b-deficient mice, and protected lupus-prone MRL/Lpr mice from end-organ injury. CD11b activation reduced TLR-dependent proinflammatory signaling in leukocytes and suppressed IFN-I signaling via an AKT/FOXO3/IFN regulatory factor 3/7 pathway. TLR-stimulated macrophages from CD11B SNP carriers showed increased basal expression of IFN regulatory factor 7 (IRF7) and IFN-β, as well as increased nuclear exclusion of FOXO3, which was suppressed by LA1-dependent activation of CD11b. This suggests that pharmacologic activation of CD11b could be a potential mechanism for developing SLE therapeutics.

Citing Articles

Unveiling macrophage dynamics and efferocytosis-related targets in diabetic kidney disease: insights from single-cell and bulk RNA-sequencing.

Zhang B, Wu Y, Wang Z, Gao S, Liu H, Lin Y Front Immunol. 2025; 16:1521554.

PMID: 40046045 PMC: 11879818. DOI: 10.3389/fimmu.2025.1521554.


Age-Associated B Cells in Autoimmune Diseases: Pathogenesis and Clinical Implications.

Xie G, Chen X, Gao Y, Yang M, Zhou S, Lu L Clin Rev Allergy Immunol. 2025; 68(1):18.

PMID: 39960645 PMC: 11832777. DOI: 10.1007/s12016-025-09021-w.


A proteogenomic analysis of cervical cancer reveals therapeutic and biological insights.

Yu J, Gui X, Zou Y, Liu Q, Yang Z, An J Nat Commun. 2024; 15(1):10114.

PMID: 39578447 PMC: 11584810. DOI: 10.1038/s41467-024-53830-0.


The multiple roles of interferon regulatory factor family in health and disease.

Wang L, Zhu Y, Zhang N, Xian Y, Tang Y, Ye J Signal Transduct Target Ther. 2024; 9(1):282.

PMID: 39384770 PMC: 11486635. DOI: 10.1038/s41392-024-01980-4.


Disturbed Complement Receptor Expression Pattern of B Cells Is Enhanced by Toll-like Receptor CD180 Ligation in Diffuse Cutaneous Systemic Sclerosis.

Erdo-Bonyar S, Rapp J, Subicz R, Borocz K, Szinger D, Filipanits K Int J Mol Sci. 2024; 25(17).

PMID: 39273179 PMC: 11394765. DOI: 10.3390/ijms25179230.


References
1.
Kariuki S, Ghodke-Puranik Y, Dorschner J, Chrabot B, Kelly J, Tsao B . Genetic analysis of the pathogenic molecular sub-phenotype interferon-alpha identifies multiple novel loci involved in systemic lupus erythematosus. Genes Immun. 2014; 16(1):15-23. PMC: 4305028. DOI: 10.1038/gene.2014.57. View

2.
Rutigliano J, Sharma S, Morris M, Oguin 3rd T, McClaren J, Doherty P . Highly pathological influenza A virus infection is associated with augmented expression of PD-1 by functionally compromised virus-specific CD8+ T cells. J Virol. 2013; 88(3):1636-51. PMC: 3911576. DOI: 10.1128/JVI.02851-13. View

3.
Macpherson M, Lek H, Prescott A, Fagerholm S . A systemic lupus erythematosus-associated R77H substitution in the CD11b chain of the Mac-1 integrin compromises leukocyte adhesion and phagocytosis. J Biol Chem. 2011; 286(19):17303-10. PMC: 3089572. DOI: 10.1074/jbc.M110.182998. View

4.
Giancotti F, Ruoslahti E . Integrin signaling. Science. 1999; 285(5430):1028-32. DOI: 10.1126/science.285.5430.1028. View

5.
Akira S, Uematsu S, Takeuchi O . Pathogen recognition and innate immunity. Cell. 2006; 124(4):783-801. DOI: 10.1016/j.cell.2006.02.015. View